Drug Pharma
- All
- News
- Videos
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Rajasthan Suspends Drug Controller Amid Cough Syrup Row
The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Jaipur-based company Kaysons Pharma, officials said.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
"No 100% Tariff On Pharma Import To US If...": What Donald Trump Said
Donald Trump on Thursday announced 100 per cent tariffs on pharmaceutical drugs, saying they will take effect on October 1.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Checkmate OTT Release Date: When and Where to Watch This Malayalam Film Online?
A gripping thriller unfolds across New York and beyond as a pharma CEO, a rising don, a widower, and a sharp lawyer get entangled in a deadly kidnapping case. With drug trials turning fatal, secrets surface, loyalties shift, and each choice pushes them deeper into a murky web of danger and truth.
-
Pharma Research To Get Boost As Government Eases Licence Norms
In a move to fast-track drug research, the Union Health Ministry is set to amend the New Drugs and Clinical Trials (NDCT) Rules, 2019, that will halve licence applications and reduce approval timelines.
-
Who Is Trump's "Brilliant, Overweight" Friend Behind Pharma Order? Internet Thinks It's Elon Musk
At a press event on Monday, announced a sweeping executive order aimed at slashing prescription drug prices in the US.
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
-
Licence Of Tamil Nadu Firm Behind 'Killer' Cough Syrup Revoked
The Tamil Nadu Drug Control department has revoked the complete licence of Sresan Pharma, which manufactured 'Coldrif' cough syrup that led to the deaths of several children across India.
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Rajasthan Suspends Drug Controller Amid Cough Syrup Row
The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Jaipur-based company Kaysons Pharma, officials said.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
"No 100% Tariff On Pharma Import To US If...": What Donald Trump Said
Donald Trump on Thursday announced 100 per cent tariffs on pharmaceutical drugs, saying they will take effect on October 1.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Checkmate OTT Release Date: When and Where to Watch This Malayalam Film Online?
A gripping thriller unfolds across New York and beyond as a pharma CEO, a rising don, a widower, and a sharp lawyer get entangled in a deadly kidnapping case. With drug trials turning fatal, secrets surface, loyalties shift, and each choice pushes them deeper into a murky web of danger and truth.
-
Pharma Research To Get Boost As Government Eases Licence Norms
In a move to fast-track drug research, the Union Health Ministry is set to amend the New Drugs and Clinical Trials (NDCT) Rules, 2019, that will halve licence applications and reduce approval timelines.
-
Who Is Trump's "Brilliant, Overweight" Friend Behind Pharma Order? Internet Thinks It's Elon Musk
At a press event on Monday, announced a sweeping executive order aimed at slashing prescription drug prices in the US.
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
